Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.70 |
| ▸ | P2RY1 | P47900 | 4/20 | 0.67 |
| ▸ | P2RY11 | Q96G91 | 1/20 | 0.67 |
| ▸ | BLM | P54132 | 3/20 | 0.66 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.66 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.66 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.64 |
| ▸ | LMNA | P02545 | 2/20 | 0.64 |
| ▸ | TSHR | P16473 | 1/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.63 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.63 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Adenosine Triphosphate SCHEMBL1948824 | 0.93 | P2RY1 (0.71) | RXFP1P2RY1P2RY11BLMLMNA | |
| Adenosine Phosphate SCHEMBL18917563 | 0.91 | RXFP1 (0.77) | RXFP1P2RY1P2RY11BLMENPP1 | |
| Adenosine Triphosphate SCHEMBL29905572 | 0.91 | P2RY1 (0.80) | P2RY1P2RY11BLMPMP22CYP2C19 | |
| Adenosine Triphosphate SCHEMBL193646 | 0.91 | P2RY1 (0.80) | P2RY1P2RY11BLMPMP22CYP2C19 | |
| Adenosine Triphosphate SCHEMBL29576424 | 0.91 | P2RY1 (0.80) | P2RY1P2RY11BLMPMP22CYP2C19 | |
| Adenosine Triphosphate SCHEMBL924732 | 0.90 | P2RY1 (0.79) | P2RY1P2RY11BLMPMP22CYP2C19 | |
| Adenosine Triphosphate SCHEMBL29007057 | 0.90 | P2RY1 (0.79) | P2RY1P2RY11BLMPMP22CYP2C19 | |
| Adenosine Triphosphate SCHEMBL3134374 | 0.90 | P2RY1 (0.79) | P2RY1P2RY11BLMPMP22CYP2C19 | |
| Adenosine Triphosphate SCHEMBL31149196 | 0.90 | P2RY1 (0.79) | P2RY1P2RY11BLMPMP22CYP2C19 | |
| Adenosine Triphosphate SCHEMBL29796747 | 0.90 | P2RY1 (0.79) | P2RY1P2RY11BLMPMP22CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8629265-B2 | Method for producing phosphate-bridged nucleoside conjugates | UNIVERSITAET HAMBURG (DE) | 2014-01-14 | — | — | US | disclosed |
| US-20110137023-A1 | METHOD FOR PRODUCING PHOSPHATE-BRIDGED NUCLEOSIDE CONJUGATES | UNIVERSITAET HAMBURG (DE) | 2011-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110137023-A1 | METHOD FOR PRODUCING PHOSPHATE-BRIDGED NUCLEOSIDE CONJUGATES | TYMP, PNP, NUDT1 | RXFP1 4802/4885P2RY1 354/4885P2RY11 471/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.